Day: July 1, 2024

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at June 30, 2024

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at June 30, 2024

HOUSTON, July 01, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2024. As of June 30, 2024, the Company’s net assets were $2.0 billion, and its net asset value per share was $11.79. As of June 30, 2024, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 621% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 453%. STATEMENT OF ASSETS AND LIABILITIES JUNE 30, 2024   // (UNAUDITED)           (in millions) Investments   $ 2,782.3   Cash...

Continue reading

Aetherium Receives Nasdaq Notice and Provides Update on Compliance Plans

Aetherium Receives Nasdaq Notice and Provides Update on Compliance Plans

GREENWICH, Conn., July 01, 2024 (GLOBE NEWSWIRE) — Aetherium Acquisition Corp. (Nasdaq: GMFI) (the “Company”) previously announced on Form 8-K that The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company on June 18, 2024, that the Nasdaq Hearings Panel (the “Panel”) is seeking to suspend trading of the Company’s securities because the Company did not regain compliance with the (i) total holder requirement under Listing Rule 5450(a)(2) and (ii) the minimum market value of listed securities (“MVLS”) requirement under Listing Rule 5450(b)(2)(A). On June 20, 2024, the Company requested a hearing before Nasdaq’s Listing Council and is preparing a plan of compliance to submit to Nasdaq on or before July 5, 2024. Pursuant to the Company’s previously approved compliance plan, which included qualifying for the Nasdaq Capital Market...

Continue reading

Alvotech Issues New Shares to Holders of Convertible Bonds

Alvotech Issues New Shares to Holders of Convertible Bonds

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, with maturity on December 20, 2025 (the “Convertible Bonds”). Today, Alvotech issued 22,073,578 new ordinary shares in exchange for Convertible Bonds, at the fixed price of US$10.00 per share. The majority of the holders of Convertible Bonds exercising their conversion right, are existing shareholders in Alvotech. Following the conversion of the Convertible Bonds into shares, the total number of issued shares in Alvotech is 324,801,040 and the total number of outstanding shares is 301,944,470. Pursuant to terms of the Convertible Bonds, the newly issued...

Continue reading

Alvotech Issues New Shares to Holders of Convertible Bonds

Alvotech Issues New Shares to Holders of Convertible Bonds

REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, with maturity on December 20, 2025 (the “Convertible Bonds”). Today, Alvotech issued 22,073,578 new ordinary shares in exchange for Convertible Bonds, at the fixed price of US$10.00 per share. The majority of the holders of Convertible Bonds exercising their conversion right, are existing shareholders in Alvotech. Following the conversion of the Convertible Bonds into shares, the total number of issued shares in Alvotech is 324,801,040 and the total number of outstanding shares is 301,944,470....

Continue reading

Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing

Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing

AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has entered into a securities purchase agreement dated June 30, 2024 with certain existing accredited shareholders and Company insiders to issue and sell an aggregate of 1,264,739 shares of its common stock (“Common Stock”) and warrants to purchase an equal number of shares of Common Stock (“Warrants”) at a combined offering price of $1.53 per share and warrant through a private placement financing (the “Offering”). Aspira anticipates the gross proceeds from the Offering will be approximately $1.935 million, before deducting offering expenses. The warrants will be exercisable for three...

Continue reading

Plains All American’s 2023 Schedule K-3 Now Available

Plains All American’s 2023 Schedule K-3 Now Available

HOUSTON, July 01, 2024 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) (the “Partnership”) today announced that its 2023 Schedule K-3 reflecting items of international tax relevance is available online. Unitholders requiring this information may access their Schedules K-3 at www.taxpackagesupport.com/plainsallamerican A limited number of unitholders (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on Schedule K-3 for their specific reporting requirements. To the extent Schedule K-3 is applicable to your federal income tax return filing needs, we encourage you to review the information contained on this form and refer to the appropriate federal laws and guidance or consult...

Continue reading

AMERANT BANK NAMES JESSE FLOWERS AS PALM BEACH MARKET PRESIDENT

AMERANT BANK NAMES JESSE FLOWERS AS PALM BEACH MARKET PRESIDENT

New Market President joins Amerant on the heels of recently announcing its third Palm Beach banking center and regional office set to open in Q1 2025 Jesse Flowers Palm Beach Market President – Amerant Bank PALM BEACH, Fl, July 01, 2024 (GLOBE NEWSWIRE) — Amerant Bank, Florida’s bank of choice with a growing presence across South Florida, has named Jesse Flowers as EVP, Palm Beach Market President. Flowers, an integral part of the financial services industry in the Palm Beach market, brings over two decades of experience in banking, specializing in servicing clients seeking a true and authentic relationship with their bank. “We are excited to welcome Jesse as Amerant’s new market president for Palm Beach County. His focus on relationship banking and his commitment to client success align perfectly with our precepts,”...

Continue reading

CrossFirst Bankshares, Inc. To Host Second Quarter 2024 Earnings Call

CrossFirst Bankshares, Inc. To Host Second Quarter 2024 Earnings Call

LEAWOOD, Kan., July 01, 2024 (GLOBE NEWSWIRE) — CrossFirst Bankshares, Inc. (Nasdaq: CFB), the parent company of CrossFirst Bank, announced today that management will host a conference call to review second quarter 2024 financial results on Tuesday, July 16, 2024, at 11:00 AM E.T. The call may also include discussion of company developments, forward-looking statements and other material information about business and financial matters. The results are scheduled to be released after the market closes on Monday, July 15, 2024. To access the event by telephone, please dial (844) 481-2831 at least fifteen minutes prior to the start of the call and request access to the CrossFirst Bankshares call. International callers should dial +1 (412) 317-1851 and request access to the CrossFirst Bankshares call. This event will also be broadcast...

Continue reading

Universal Stainless Reports North Jackson Labor Contract Continuance

Universal Stainless Reports North Jackson Labor Contract Continuance

BRIDGEVILLE, Pa., July 01, 2024 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) reported today that it has agreed with Local 2332-2 of the United Steelworkers to a seventeen-day continuance of the collective bargaining agreement covering the hourly production and maintenance employees at the Company’s North Jackson facility, subject to a 7-day termination notice by either party. The continuance provides additional time to negotiate a mutually acceptable labor agreement. During the continuance, the employees will work under the terms and conditions of the prior agreement, which otherwise would have expired at midnight on June 30, 2024. The North Jackson facility melts VIM quality specialty steel and nickel alloy products, as well as doing VAR remelting. The facility also operates a state-of-the-art...

Continue reading

Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing

Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing

DENVER, July 01, 2024 (GLOBE NEWSWIRE) — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced that its common stock will soon transition to the OTC Expert Market, under the ticker symbol “SHWZ” due to the Company’s delayed filing of its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (“SEC”). The delay was a result of an SEC Order regarding the Company’s previous auditor, BF Borgers CPA PC (“BF Borgers”), who was dismissed as Schwazze’s auditor prior to the SEC’s Order. As previously announced on April 8, 2024, Schwazze dismissed BF Borgers as its independent registered public accountant and engaged Baker Tilly US, LLP (“Baker Tilly”) as its new independent accountant. Subsequent to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.